These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Development of phospho-specific Rab protein antibodies to monitor Lis P; Burel S; Steger M; Mann M; Brown F; Diez F; Tonelli F; Holton JL; Ho PW; Ho SL; Chou MY; Polinski NK; Martinez TN; Davies P; Alessi DR Biochem J; 2018 Jan; 475(1):1-22. PubMed ID: 29127256 [TBL] [Abstract][Full Text] [Related]
9. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human. Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203 [TBL] [Abstract][Full Text] [Related]
10. The Michael J. Fox Foundation's Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson Disease. Padmanabhan S; Fiske BK; Baptista MAS Cells; 2020 Aug; 9(8):. PubMed ID: 32796584 [TBL] [Abstract][Full Text] [Related]
11. Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites. Nirujogi RS; Tonelli F; Taylor M; Lis P; Zimprich A; Sammler E; Alessi DR Biochem J; 2021 Jan; 478(2):299-326. PubMed ID: 33367571 [TBL] [Abstract][Full Text] [Related]
12. LRRK2 and Parkinson's Disease: From Lack of Structure to Gain of Function. Blanca Ramírez M; Madero-Perez J; Rivero-Rios P; Martinez-Salvador M; Lara Ordonez AJ; Fernandez B; Fdez E; Hilfiker S Curr Protein Pept Sci; 2017; 18(7):677-686. PubMed ID: 26965688 [TBL] [Abstract][Full Text] [Related]
13. The Roc-COR tandem domain of leucine-rich repeat kinase 2 forms dimers and exhibits conventional Ras-like GTPase properties. Mills RD; Liang LY; Lio DS; Mok YF; Mulhern TD; Cao G; Griffin M; Kenche VB; Culvenor JG; Cheng HC J Neurochem; 2018 Nov; 147(3):409-428. PubMed ID: 30091236 [TBL] [Abstract][Full Text] [Related]
16. Pathogenic LRRK2 regulates ciliation probability upstream of tau tubulin kinase 2 via Rab10 and RILPL1 proteins. Sobu Y; Wawro PS; Dhekne HS; Yeshaw WM; Pfeffer SR Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33653948 [TBL] [Abstract][Full Text] [Related]
17. The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A. Rivero-Ríos P; Romo-Lozano M; Madero-Pérez J; Thomas AP; Biosa A; Greggio E; Hilfiker S J Biol Chem; 2019 Mar; 294(13):4738-4758. PubMed ID: 30709905 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the WD40 domain dimer of LRRK2. Zhang P; Fan Y; Ru H; Wang L; Magupalli VG; Taylor SS; Alessi DR; Wu H Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1579-1584. PubMed ID: 30635421 [TBL] [Abstract][Full Text] [Related]
19. Detection of Substrate Phosphorylation of LRRK2 in Tissues and Cultured Cells. Ito K; Xu L; Ito G; Tomita T Methods Mol Biol; 2021; 2322():53-61. PubMed ID: 34043192 [TBL] [Abstract][Full Text] [Related]